Upon further investigations, they discovered that senkyunolide A and ligustilide are the active anti-inflammatory components in LC, and these two lactones are able to suppress the secretion of TNF-α directly and reduce inducible nitric oxide synthase (iNOS) activity [15]. This evidence concerns the gene NOS2 and laryngotracheoesophageal cleft.